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Abstract 
 
Despite recent advances in tuberculosis (TB) research, shortage of knowledge still exists that limits 
the understanding of host-pathogen interactions in human TB. Cell-mediated immunity has been 
shown to confer protection in TB, although the relative importance of cytolytic T cells (CTLs) 
expressing granule-associated effector molecules perforin and granulysin is debated. A typical 
hallmark of TB is granuloma formation, which includes organized collections of immune cells that 
form around Mycobacterium tuberculosis (Mtb)-infected macrophages to contain Mtb infection in 
the tissue. This thesis aimed to increase insights to the immunopathogenesis involved in the 
progression of clinical TB, with an emphasis to explore antimicrobial effector cell responses at the 
local site of Mtb infection.  
 
A technological platform including quantitative PCR and in situ computerized image analysis was 
established to enable assessment of local immune responses in tissues collected from lung or lymph 
nodes of patients with active pulmonary TB or extrapulmonary TB. The results from this thesis 
revealed enhanced inflammation and granuloma formation in Mtb-infected organs from patients 
with active TB disease. CD68+ macrophages expressing the Mtb-specific antigen MPT64 were 
abundantly present inside the granulomas, which suggest that the granuloma is the main site of 
bacterial persistence. Macrophages expressed nitric oxide, while the antimicrobial peptide LL-37 
was very low in TB lung lesions compared to distal lung parenchyma. Mtb-infected tissues and 
particularly the granulomas were enriched with CD3+ T cells, CD4+ T cells and FoxP3+ regulatory 
T cells (Treg), while the numbers of CD8+ CTLs expressing perforin and granulysin were very low 
inside the granulomatous lesions. We further observed that mRNA expression of important 
Th1/Th17 cytokines were not up-regulated in the Mtb-infected tissues. Instead, IL-13 and TGF-β 
were elevated in lymph node TB, which may suggest a shift of the cytokine response towards a Th2 
or immunoregulatory profile. We also detected elevated levels of the B cell stimulatory cytokine 
IL-21, but also IL-10 in TB lesions from patients with pulmonary TB. Accordingly, chronic TB 
was associated with an increased expression of CD20+ B cells and IgG-secreting cells as well as 
FoxP3+ Treg cells in the TB lung lesions. This may suggest that adverse immune responses in 
progressive TB disease involve enhanced activities of plasma B cells and Treg cells. Next, our 
findings of impaired CTL responses in human TB were applied to evaluate a novel TB vaccine 
candidate in a non-human primate model of TB. Our in situ technology was used to show that 
CD8+ T cells as well as perforin, granulysin and the survival cytokine IL-7, were induced locally in 
the lungs but also spleens of animals that were primed with the novel TB vaccine before Mtb 
challenge. Thus, immune correlates of protection discovered in human TB could be used as 
potential biomarkers to evaluate the immunogenicity of novel TB vaccine candidates. 
 
Taken together, our results provide evidence of an impaired CD8+ CTL response at the site of Mtb 
infection that involves deficient expression of perforin and granulysin. Instead, chronic TB is 
associated with enhanced levels of antibody-producing B cells with little documented protection in 
TB. We propose that the induction of Th2 or immunoregulatory cytokines and FoxP3+ Treg cells 
represents potential immunopathogenic processes that may contribute to impaired cytolytic and 
antimicrobial effector cell responses in human TB. 
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